메뉴 건너뛰기




Volumn 65, Issue 9, 2005, Pages 1508-1509

Nonresponsiveness to anticholinesterase agents in patients with MuSK-antibody-positive MG

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; EDROPHONIUM; MUSCLE SPECIFIC TYROSINE KINASE ANTIBODY; PYRIDOSTIGMINE; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

EID: 27644458160     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000183145.91579.74     Document Type: Article
Times cited : (102)

References (7)
  • 1
    • 0035105784 scopus 로고    scopus 로고
    • Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies
    • Hoch W, McConville J, Helms S, et al. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 2001;7:365-368.
    • (2001) Nat Med , vol.7 , pp. 365-368
    • Hoch, W.1    McConville, J.2    Helms, S.3
  • 2
    • 0038038032 scopus 로고    scopus 로고
    • Clinical aspects of MuSK antibody positive seronegative MG
    • Sanders DB, El-Salem K, Massey JM, et al. Clinical aspects of MuSK antibody positive seronegative MG. Neurology 2003;60:1978-1980.
    • (2003) Neurology , vol.60 , pp. 1978-1980
    • Sanders, D.B.1    El-Salem, K.2    Massey, J.M.3
  • 3
    • 0242336467 scopus 로고    scopus 로고
    • Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis
    • Evoli A, Tonali PA, Padua L, et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 2003;126:2304-2311.
    • (2003) Brain , vol.126 , pp. 2304-2311
    • Evoli, A.1    Tonali, P.A.2    Padua, L.3
  • 4
    • 0026680625 scopus 로고
    • Diagnostic sensitivity of the laboratory tests in myasthenia gravis
    • Oh SJ, Kim DE, Kuruoglu R, et al. Diagnostic sensitivity of the laboratory tests in myasthenia gravis. Muscle Nerve 1992;15:720-724.
    • (1992) Muscle Nerve , vol.15 , pp. 720-724
    • Oh, S.J.1    Kim, D.E.2    Kuruoglu, R.3
  • 5
    • 17644369970 scopus 로고    scopus 로고
    • Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis
    • Nemoto Y, Kuwabara S, Misawa S, et al. Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis. J Neurol Neurosurg Psychiatry 2005;76:714-718.
    • (2005) J Neurol Neurosurg Psychiatry , vol.76 , pp. 714-718
    • Nemoto, Y.1    Kuwabara, S.2    Misawa, S.3
  • 6
    • 0043013332 scopus 로고    scopus 로고
    • Seronegative generalized myasthenia gravis: Clinical features, antibodies, and their targets
    • Vincet A, Bowen J, Newsom-Davis J, et al. Seronegative generalized myasthenia gravis: clinical features, antibodies, and their targets. Lancet Neurol 2003;2:99-106.
    • (2003) Lancet Neurol , vol.2 , pp. 99-106
    • Vincet, A.1    Bowen, J.2    Newsom-Davis, J.3
  • 7
    • 3042852639 scopus 로고    scopus 로고
    • Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients
    • Zhou L, McConville J, Chaudhry V, et al. Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients. Muscle Nerve 2004;30:55-60.
    • (2004) Muscle Nerve , vol.30 , pp. 55-60
    • Zhou, L.1    McConville, J.2    Chaudhry, V.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.